Related Topics News -

     
 Title only   |   Print    Next page > 
     
博安生物BA2201獲批於中國臨床

2026-11-06T  
博安生物地舒單抗注射液在日本達成授權合作

2026-10-30T  
博安生物BA1203中國I期臨床試驗完成首例受試者入組

2026-10-23T  
博安生物BA1203獲批內地臨床

2026-09-15T  
《業績》博安生物中期虧損8,301萬人民幣 盈轉虧

2026-08-28T  
博安生物BA2201臨床試驗申請獲受理

2026-08-26T  
博安生物BA1302完成中國Ia期臨床研究

2026-08-16T  
《盈警》博安生物研發開支增加 預告中績見紅

2026-08-16T  
博安生物眼內注射溶液BA9101在巴西提交上市申請

2026-08-05T  
博安生物度拉糖肽注射液完成在美國授權

2026-06-12T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.